Carregant...
Erythropoietin produced by genetic-modified NIH/3T3 fibroblasts enhances the survival of degenerating neurons
BACKGROUND: Erythropoietin (EPO) has potent neuroprotective effects. The short-term delivery of high-dose EPO seemed to improve patients’ neuromuscular functions; however, excessive EPO resulted in systematically high hematocrit and thrombotic risk. In our study, we established a cellular material f...
Guardat en:
| Publicat a: | Brain Behav |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559019/ https://ncbi.nlm.nih.gov/pubmed/26357589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.356 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|